Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ravin Ratan
Shreyaskumar R Patel

Cancer

Showing results (1-10 of 24) with videos related to

Pageof 3
Sort By:
Cancer|July 20, 2016
Chemotherapy for soft tissue sarcomaRavin Ratan, Shreyaskumar R Patel
Cancer|May 11, 2021
An updated review of the treatment landscape for advanced gastrointestinal stromal tumorsShreyaskumar R Patel, Peter Reichardt
Cancer|December 9, 2020
Real-world outcomes of patients with locally advanced or metastatic epithelioid sarcomaMrinal M Gounder, Priscilla Merriam, Ravin Ratan, et al.
Cancer|May 27, 2003
Results of a 2-arm Phase II study of 9-nitrocamptothecin in patients with advanced soft-tissue sarcomasShreyaskumar R Patel, Jennifer Beach, Nicholas Papadopoulos, et al.
Cancer|December 12, 2003
A two-arm phase II study of temozolomide in patients with advanced gastrointestinal stromal tumors and other soft tissue sarcomasJonathan C Trent, Jennifer Beach, Michael A Burgess, et al.
Cancer|May 7, 2003
Surgical margins and reresection in the management of patients with soft tissue sarcoma using conservative surgery and radiation therapyGunar K Zagars, Matthew T Ballo, Peter W T Pisters, et al.
Cancer|May 7, 2003
Prognostic factors for patients with localized soft-tissue sarcoma treated with conservation surgery and radiation therapy: an analysis of 1225 patientsGunar K Zagars, Matthew T Ballo, Peter W T Pisters, et al.
Cancer|September 26, 2006
Correlation of immunophenotype with progression-free survival in patients with gastrointestinal stromal tumors treated with imatinib mesylateLucian R Chirieac, Jonathan C Trent, Dejka M Steinert, et al.
Cancer|September 11, 2019
Safety and efficacy of trabectedin when administered in the inpatient versus outpatient setting: Clinical considerations for outpatient administration of trabectedinRobin L Jones, Robert G Maki, Shreyaskumar R Patel, et al.
Cancer|July 19, 2002
Adult rhabdomyosarcoma: outcome following multimodality treatmentDarren J Little, Matthew T Ballo, Gunar K Zagars, et al.
Pageof 3

Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
Cancer|July 20, 2016
Chemotherapy for soft tissue sarcomaRavin Ratan, Shreyaskumar R Patel
Cancer|May 11, 2021
An updated review of the treatment landscape for advanced gastrointestinal stromal tumorsShreyaskumar R Patel, Peter Reichardt
Cancer|December 9, 2020
Real-world outcomes of patients with locally advanced or metastatic epithelioid sarcomaMrinal M Gounder, Priscilla Merriam, Ravin Ratan, et al.
Cancer|May 27, 2003
Results of a 2-arm Phase II study of 9-nitrocamptothecin in patients with advanced soft-tissue sarcomasShreyaskumar R Patel, Jennifer Beach, Nicholas Papadopoulos, et al.
Cancer|December 12, 2003
A two-arm phase II study of temozolomide in patients with advanced gastrointestinal stromal tumors and other soft tissue sarcomasJonathan C Trent, Jennifer Beach, Michael A Burgess, et al.
Cancer|May 7, 2003
Surgical margins and reresection in the management of patients with soft tissue sarcoma using conservative surgery and radiation therapyGunar K Zagars, Matthew T Ballo, Peter W T Pisters, et al.
Cancer|May 7, 2003
Prognostic factors for patients with localized soft-tissue sarcoma treated with conservation surgery and radiation therapy: an analysis of 1225 patientsGunar K Zagars, Matthew T Ballo, Peter W T Pisters, et al.
Cancer|September 26, 2006
Correlation of immunophenotype with progression-free survival in patients with gastrointestinal stromal tumors treated with imatinib mesylateLucian R Chirieac, Jonathan C Trent, Dejka M Steinert, et al.
Cancer|September 11, 2019
Safety and efficacy of trabectedin when administered in the inpatient versus outpatient setting: Clinical considerations for outpatient administration of trabectedinRobin L Jones, Robert G Maki, Shreyaskumar R Patel, et al.
Cancer|July 19, 2002
Adult rhabdomyosarcoma: outcome following multimodality treatmentDarren J Little, Matthew T Ballo, Gunar K Zagars, et al.
Pageof 3